Surgical & Medical Instruments & Apparatus · DE · CIK 872912
Treats cancers primary or metastatic to the liver using drug/device combinations
Comparable business profile · signals at a glance
In the 90 days to Mar 6, 2026: 2 insiders bought $150K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Pennell SandraChief Financial Officer | Buy | 5,533 | $9.04 | $50K |
| Mar 2, 2026 | Michel Gerard JCHIEF EXECUTIVE OFFICER | Buy | 11,200 | $8.96 | $100K |
| Nov 21, 2025 | Sylvester John RichardDirector | Buy | 4,386 | $8.89 | $39K |
| Nov 11, 2025 | Michel Gerard JCHIEF EXECUTIVE OFFICER | Buy | 11,500 | $8.53 | $98K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.